Xiaoling Song1, Ying Huang2, Marian L Neuhouser2,3, Lesley F Tinker2, Mara Z Vitolins4, Ross L Prentice2,3, Johanna W Lampe2,3. 1. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA; xsong2@fredhutch.org. 2. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA. 3. School of Public Health, University of Washington, Seattle, WA; and. 4. Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC.
Abstract
Background: Biomarkers of macronutrient intake are lacking. Controlled human feeding studies that preserve the normal variation in nutrient and food consumption are necessary for the development and validation of robust nutritional biomarkers.Objective: We aimed to assess the utility of serum phospholipid fatty acids (PLFAs) as biomarkers of dietary intakes of fatty acids, total fat, and carbohydrate.Design: We used an individualized controlled feeding study in which 153 postmenopausal women from the Women's Health Initiative (WHI) were provided with a 2-wk controlled diet that mimicked each individual's habitual food intake. A total of 41 PLFAs were measured with the use of gas chromatography in end-of-feeding-period fasting serum samples and expressed in both relative and absolute concentrations. R2 values (percentages of variation explained) from linear regressions of (ln-transformed) consumed fatty acids (individual, groups, and broad categories) on (ln-transformed) corresponding measures of serum PLFAs alone and together with selected participant-related variables (age, race/ethnicity, body mass index, season of study participation, education level, and estimated energy intake from doubly labeled water) were used for evaluation against established urinary recovery biomarkers of energy and protein intake as benchmarks. Models to predict intakes of other nutrients were also explored. Results: Intakes of eicosapentaenoic acid and docosahexaenoic acid achieved the benchmark of R2 > 36% with or without covariates. When all 41 serum PLFAs and participant-related covariates were initially included in the model for selection, cross-validated R2 achieved >36% for consumed total carbohydrate (grams per day), total saturated fatty acids (SFAs), percentage of energy from SFAs, and total trans fatty acids with serum PLFAs in both relative and absolute concentrations.Conclusions: Serum PLFA biomarkers perform similarly to established energy and protein urinary recovery biomarkers in describing intake variations for several nutrients and, thus, appear suitable for application in this population of postmenopausal women. This approach represents an important methodologic contribution toward the utilization of nutritional biomarkers to assess macronutrient intake. This trial was registered at clinicaltrials.gov as NCT00000611.
Background: Biomarkers of macronutrient intake are lacking. Controlled human feeding studies that preserve the normal variation in nutrient and food consumption are necessary for the development and validation of robust nutritional biomarkers.Objective: We aimed to assess the utility of serum phospholipid fatty acids (PLFAs) as biomarkers of dietary intakes of fatty acids, total fat, and carbohydrate.Design: We used an individualized controlled feeding study in which 153 postmenopausal women from the Women's Health Initiative (WHI) were provided with a 2-wk controlled diet that mimicked each individual's habitual food intake. A total of 41 PLFAs were measured with the use of gas chromatography in end-of-feeding-period fasting serum samples and expressed in both relative and absolute concentrations. R2 values (percentages of variation explained) from linear regressions of (ln-transformed) consumed fatty acids (individual, groups, and broad categories) on (ln-transformed) corresponding measures of serum PLFAs alone and together with selected participant-related variables (age, race/ethnicity, body mass index, season of study participation, education level, and estimated energy intake from doubly labeled water) were used for evaluation against established urinary recovery biomarkers of energy and protein intake as benchmarks. Models to predict intakes of other nutrients were also explored. Results: Intakes of eicosapentaenoic acid and docosahexaenoic acid achieved the benchmark of R2 > 36% with or without covariates. When all 41 serum PLFAs and participant-related covariates were initially included in the model for selection, cross-validated R2 achieved >36% for consumed total carbohydrate (grams per day), total saturated fatty acids (SFAs), percentage of energy from SFAs, and total trans fatty acids with serum PLFAs in both relative and absolute concentrations.Conclusions: Serum PLFA biomarkers perform similarly to established energy and protein urinary recovery biomarkers in describing intake variations for several nutrients and, thus, appear suitable for application in this population of postmenopausal women. This approach represents an important methodologic contribution toward the utilization of nutritional biomarkers to assess macronutrient intake. This trial was registered at clinicaltrials.gov as NCT00000611.
Authors: Marian L Neuhouser; Chongzhi Di; Lesley F Tinker; Cynthia Thomson; Barbara Sternfeld; Yasmin Mossavar-Rahmani; Marcia L Stefanick; Stacy Sims; J David Curb; Michael Lamonte; Rebecca Seguin; Karen C Johnson; Ross L Prentice Journal: Am J Epidemiol Date: 2013-02-22 Impact factor: 4.897
Authors: Ross L Prentice; Yasmin Mossavar-Rahmani; Ying Huang; Linda Van Horn; Shirley A A Beresford; Bette Caan; Lesley Tinker; Dale Schoeller; Sheila Bingham; Charles B Eaton; Cynthia Thomson; Karen C Johnson; Judy Ockene; Gloria Sarto; Gerardo Heiss; Marian L Neuhouser Journal: Am J Epidemiol Date: 2011-07-15 Impact factor: 4.897
Authors: Johanna W Lampe; Ying Huang; Marian L Neuhouser; Lesley F Tinker; Xiaoling Song; Dale A Schoeller; Soyoung Kim; Daniel Raftery; Chongzhi Di; Cheng Zheng; Yvonne Schwarz; Linda Van Horn; Cynthia A Thomson; Yasmin Mossavar-Rahmani; Shirley Aa Beresford; Ross L Prentice Journal: Am J Clin Nutr Date: 2016-12-28 Impact factor: 7.045
Authors: Hee Young Yun; Lesley F Tinker; Marian L Neuhouser; Dale A Schoeller; Yasmin Mossavar-Rahmani; Linda G Snetselaar; Linda V Van Horn; Charles B Eaton; Ross L Prentice; Johanna W Lampe; Diane M O'Brien Journal: J Nutr Date: 2020-10-12 Impact factor: 4.798
Authors: Hee Young Yun; Johanna W Lampe; Lesley F Tinker; Marian L Neuhouser; Shirley A A Beresford; Kristine R Niles; Yasmin Mossavar-Rahmani; Linda G Snetselaar; Linda Van Horn; Ross L Prentice; Diane M O'Brien Journal: J Nutr Date: 2018-12-01 Impact factor: 4.798
Authors: Cheng Zheng; G A Nagana Gowda; Daniel Raftery; Marian L Neuhouser; Lesley F Tinker; Ross L Prentice; Shirley A A Beresford; Yiwen Zhang; Lisa Bettcher; Robert Pepin; Danijel Djukovic; Haiwei Gu; Gregory A Barding; Xiaoling Song; Johanna W Lampe Journal: Eur J Nutr Date: 2021-05-15 Impact factor: 5.614
Authors: Fred K Tabung; Liming Liang; Tianyi Huang; Raji Balasubramanian; Yibai Zhao; Paulette D Chandler; JoAnn E Manson; Elizabeth M Cespedes Feliciano; Kathleen M Hayden; Linda Van Horn; Clary B Clish; Edward L Giovannucci; Kathryn M Rexrode Journal: Clin Nutr Date: 2019-06-17 Impact factor: 7.324
Authors: Marian L Neuhouser; Mary Pettinger; Johanna W Lampe; Lesley F Tinker; Stephanie M George; Jill Reedy; Xiaoling Song; Bharat Thyagarajan; Shirley A Beresford; Ross L Prentice Journal: Am J Epidemiol Date: 2021-11-02 Impact factor: 4.897
Authors: Fumiaki Imamura; Amanda M Fretts; Matti Marklund; Andres V Ardisson Korat; Wei-Sin Yang; Maria Lankinen; Waqas Qureshi; Catherine Helmer; Tzu-An Chen; Jyrki K Virtanen; Kerry Wong; Julie K Bassett; Rachel Murphy; Nathan Tintle; Chaoyu Ian Yu; Ingeborg A Brouwer; Kuo-Liong Chien; Yun-Yu Chen; Alexis C Wood; Liana C Del Gobbo; Luc Djousse; Johanna M Geleijnse; Graham G Giles; Janette de Goede; Vilmundur Gudnason; William S Harris; Allison Hodge; Frank Hu; Albert Koulman; Markku Laakso; Lars Lind; Hung-Ju Lin; Barbara McKnight; Kalina Rajaobelina; Ulf Riserus; Jennifer G Robinson; Cecilia Samieri; Mackenzie Senn; David S Siscovick; Sabita S Soedamah-Muthu; Nona Sotoodehnia; Qi Sun; Michael Y Tsai; Tomi-Pekka Tuomainen; Matti Uusitupa; Lynne E Wagenknecht; Nick J Wareham; Jason H Y Wu; Renata Micha; Rozenn N Lemaitre; Dariush Mozaffarian; Nita G Forouhi Journal: PLoS Med Date: 2020-06-12 Impact factor: 11.069